HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Li Selected Research

Anna Li Research Topics

Disease

4Pain (Aches)
11/2021 - 01/2020
4Neoplasms (Cancer)
12/2020 - 09/2004
3Inflammation (Inflammations)
01/2022 - 11/2020
2Stroke (Strokes)
12/2022 - 01/2008
2Infections
12/2021 - 01/2019
2Chronic Pain
01/2021 - 01/2020
2Hemorrhage
04/2019 - 11/2007
2Nasopharyngeal Carcinoma
01/2019 - 10/2003
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2017 - 12/2015
1Infarction (Infarctions)
12/2022
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2022
1Ischemic Stroke
12/2022
1Leukemia
01/2022
1Pre-Eclampsia (Preeclampsia)
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Bronchiectasis
12/2021
1Cystic Fibrosis (Mucoviscidosis)
12/2021
1Pneumonia (Pneumonitis)
02/2021
1Rheumatoid Arthritis
01/2021
1Arthritis (Polyarthritis)
01/2021
1Ulcer
12/2020
1Proteinuria
11/2020
1Breast Neoplasms (Breast Cancer)
11/2019
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2019
1Neutropenia
01/2019
1Mycoses (Diseases, Fungus)
01/2019
1Disease Progression
01/2019
1Osteoporosis
07/2017
1Bone Resorption
07/2017
1Bone Fractures (Bone Fracture)
01/2014
1Schizophrenia (Dementia Praecox)
01/2012
1Cryptosporidiosis
11/2010
1Giardiasis
11/2010
1Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
05/2009
1Melanoma (Melanoma, Malignant)
05/2009
1Hemophilia B (Haemophilia B)
11/2007

Drug/Important Bio-Agent (IBA)

2RNA (Ribonucleic Acid)IBA
12/2022 - 01/2012
2KetamineFDA LinkGeneric
11/2021 - 01/2020
2Glutamic Acid (Glutamate)FDA Link
01/2021 - 01/2021
2AMPA Receptors (AMPA Receptor)IBA
01/2021 - 01/2021
2Proteins (Proteins, Gene)FDA Link
12/2015 - 05/2015
2AntigensIBA
11/2010 - 05/2009
1LipidsIBA
12/2022
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2022
1AnthracyclinesIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2022
1Biological ProductsIBA
01/2022
1olaparibIBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
12/2021
1ChloridesIBA
12/2021
1ivacaftorIBA
12/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2021
1Paclitaxel (Taxol)FDA LinkGeneric
02/2021
1AcidsIBA
01/2021
1AutoantibodiesIBA
01/2021
1IsomerasesIBA
01/2021
11- (1,4- benzodioxan- 6- ylcarbonyl)piperidineIBA
01/2021
1Immune Checkpoint InhibitorsIBA
12/2020
1Proton Pump InhibitorsIBA
12/2020
1resolvin D1IBA
11/2020
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2020
1Freund's AdjuvantIBA
01/2020
1DDTIBA
11/2019
1ORALIT (ORS)IBA
11/2019
12,3',4,4',5-pentachlorobiphenylIBA
11/2019
12,4,4'-trichlorobiphenylIBA
11/2019
1Dichlorodiphenyl Dichloroethylene (DDE)IBA
11/2019
12,4,5,2',4',5'-hexachlorobiphenylIBA
11/2019
1Polychlorinated Biphenyls (PCBs)IBA
11/2019
1Inosine Triphosphate (ITP)IBA
04/2019
1Interleukin-11 (Interleukin 11)IBA
04/2019
1CadmiumIBA
01/2019
1Tyrosine Kinase InhibitorsIBA
08/2017
1Vitamin DFDA LinkGeneric
07/2017
1Calcitriol (Calcijex)FDA LinkGeneric
07/2017
1Type I Bone Morphogenetic Protein ReceptorsIBA
07/2017
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
05/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
03/2013
1DNA (Deoxyribonucleic Acid)IBA
03/2013
1Messenger RNA (mRNA)IBA
01/2012
1Immunoglobulin G (IgG)IBA
11/2010
1AntibodiesIBA
11/2010
1EpitopesIBA
11/2010
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2010
1Neoplasm Antigens (Tumor Antigens)IBA
05/2009
1GATA1 Transcription FactorIBA
05/2009
1myosin VIIBA
01/2008
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
11/2007

Therapy/Procedure

2Therapeutics
12/2020 - 10/2003
1Aftercare (After-Treatment)
12/2021
1Brain-Computer Interfaces
06/2021
1Transplantation
11/2020
1Drug Therapy (Chemotherapy)
01/2019
1Cell Transplantation
01/2019
1Injections
09/2004